MX9400040A - COMPOSITIONS FOR TREATING RESPIRATORY DISORDERS. - Google Patents

COMPOSITIONS FOR TREATING RESPIRATORY DISORDERS.

Info

Publication number
MX9400040A
MX9400040A MX9400040A MX9400040A MX9400040A MX 9400040 A MX9400040 A MX 9400040A MX 9400040 A MX9400040 A MX 9400040A MX 9400040 A MX9400040 A MX 9400040A MX 9400040 A MX9400040 A MX 9400040A
Authority
MX
Mexico
Prior art keywords
compositions
respiratory disorders
treating respiratory
cold
antipode
Prior art date
Application number
MX9400040A
Other languages
Spanish (es)
Inventor
Richard Wilfred D Souza
Sekhar Mitra
Michael James Simone
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9400040A publication Critical patent/MX9400040A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

La presente invención se refiere a composiciones y métodos para proveer tratamiento, manejo o atenuación mejorados de los síntomas del resfriado, similares al resfriado y/o influencia mediante la administración de una cantidad segura y efectiva de una composición que comprende un agente substancialmente libre de su antípoda R (-) seleccionado del grupo que consiste de (S+)-ibuprofen, (S+) flurbiprofen y (S+) cetoprofen, sus sales farmacéuticamente aceptables y mezclas de los mismos así como por lo menos uno de (a) un descongestionante, (b) un expectorante y (c) un antitusivo.The present invention relates to compositions and methods for providing improved treatment, management, or attenuation of cold, cold-like, and / or influence symptoms by administering a safe and effective amount of a composition comprising an agent substantially free of its R (-) antipode selected from the group consisting of (S +) - ibuprofen, (S +) flurbiprofen and (S +) ketoprofen, their pharmaceutically acceptable salts and mixtures thereof as well as at least one of (a) a decongestant, ( b) an expectorant and (c) an antitussive.

MX9400040A 1992-12-21 1994-01-03 COMPOSITIONS FOR TREATING RESPIRATORY DISORDERS. MX9400040A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99970192A 1992-12-21 1992-12-21

Publications (1)

Publication Number Publication Date
MX9400040A true MX9400040A (en) 1994-07-29

Family

ID=25546608

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9400040A MX9400040A (en) 1992-12-21 1994-01-03 COMPOSITIONS FOR TREATING RESPIRATORY DISORDERS.

Country Status (5)

Country Link
EP (1) EP0674527A1 (en)
JP (1) JPH08506808A (en)
CA (1) CA2151912A1 (en)
MX (1) MX9400040A (en)
WO (1) WO1994014476A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
WO1998052545A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
CA2459492A1 (en) * 2001-09-04 2003-03-13 Boehringer Ingelheim International Gmbh Anti-influenzal agent
DE10203104A1 (en) * 2002-01-25 2003-08-07 Boehringer Ingelheim Pharma Ambroxol for the treatment of chronic pain
TWI313598B (en) * 2002-12-18 2009-08-21 Wyeth Corp Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US20050192355A1 (en) * 2004-02-17 2005-09-01 Wyeth Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
KR20100033405A (en) 2007-07-12 2010-03-29 지이 헬스케어 에이에스 Contrast agents
JP5364330B2 (en) * 2007-10-10 2013-12-11 第一三共ヘルスケア株式会社 Pharmaceutical composition containing azelastine and ambroxol
WO2015163832A1 (en) 2014-04-25 2015-10-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. An ibuprofen and famotidine combined composition having improved stability

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
CA2107331A1 (en) * 1991-04-01 1992-10-02 Robert T. Sims Ibuprofen-decongestant combinations
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations

Also Published As

Publication number Publication date
WO1994014476A1 (en) 1994-07-07
JPH08506808A (en) 1996-07-23
CA2151912A1 (en) 1994-07-07
EP0674527A1 (en) 1995-10-04

Similar Documents

Publication Publication Date Title
ES2082288T3 (en) THERAPEUTIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF KETOROLACO.
ES2164040T1 (en) USE OF AGONISTS OF THE GLICINE UNION SITE OR INHIBITORS OF GLYCIN ABSORPTION FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS.
CO2022013777A2 (en) Use of agents for the treatment of respiratory conditions
AR035533A1 (en) USE OF AT LEAST AN INHIBITOR OF THE ABSORPTION OF THE STEROLS OR THEIR SALTS, SOLVATOS, PHARMACEUTICALLY ACCEPTABLE DRUGS OR MIXTURES OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF SITOSTEROLEMIA, COMPOSITIONS OF THE PHARMACEUTICAL USE
ATE157257T1 (en) ENHANCEMENT OF SUPPRESSIVE REGULATION OF AUTOIMMUNE DISEASES BY ORAL OR ENTERAL ADMINISTRATION OF AUTOANTIGENS
DK0682514T3 (en) Use of local anesthetic agents for the manufacture of a medicament for the treatment of bronchial asthma
ES2162615T3 (en) METHOD TO TREAT OR PREVENT TYPE 1 DIABETES THROUGH ORAL INSULIN ADMINISTRATION.
ES2176600T3 (en) DERIVATIVE OF PROPIOFENONE AND PROCEDURES FOR PREPARATION.
KR960703009A (en) Use of modafinil for the treatment of centrally-derived sleep apnea and dyspnea
ES2194025T3 (en) MULTIPLE BOTULINIC TOXINS TO TREAT DISORDERS AND NEUROMUSCULAR DISEASES.
CO5670327A2 (en) PROCEDURE FOR THE TREATMENT OF DEPRESSION AND ANXIETY DISORDERS THROUGH COMBINATION THERAPY
MX9304435A (en) PHARMACEUTICAL COMPOSITION AND COMPOSITION FOR THE TREATMENT AND PROPHYLAXIS OF OBESITY OR FOR THE TREATMENT OF TYPE II DIABETES.
MX9400040A (en) COMPOSITIONS FOR TREATING RESPIRATORY DISORDERS.
DE60034344D1 (en) METHOD FOR TREATING THE SYMPTOMS OF HORMONAL CHANGES, INCLUDING HEAD FORESTS
IL128723A0 (en) Pharmaceutical compositions containing rar antagonists and rxr agonists
RU94002337A (en) Pharmaceutical composition, use of gamma-linolenic acid or dihomo-gamma-linolenic acid for damage treatment after irradiation, treatment method
CO5011084A1 (en) COMPOSITIONS AND METHODS TO TREAT RESPIRATORY DISORDERS
MX163574B (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR INHALATION CONTAINING A GANGLIOSIDE
Kumar et al. Coal tar therapy in paimoplantar psoriasis: old wine in an old bottle?
CO5160295A1 (en) NEW PHARMACEUTICAL COMBINATIONS FOR INHIBITORS OF THE US A SSRI
FI962550A0 (en) Deuterated active substances for transdermal use
ATE126061T1 (en) USE OF LITHIUM FOR THE TREATMENT OR PROPHYLAXIS OF MOLLUSCUM CONTAGIUSUM.
MX173156B (en) COMPOSITIONS TO TREAT OR AVOID THE DENTAL PLATE OR GINGIVAL OR PERIODONTAL DISEASES OF THE ORAL CAVITY IN HUMANS OR LOWER ANIMALS
AR012751A1 (en) HYDROGEN SALTS TARTRATE OF (R) -3-N, N-DICICLOBUTILAMINO-8-FLUORO-3,4 -DIHIDRO-2H-1-BENZOPIRAN-5-CARBOXAMIDA, ITS USE FOR THE MANUFACTURE OF MEDICINES TO TREAT SNC DISORDERS AND RELATED MEDICAL DISORDERS AND PROCEDURE FOR THE MANUFACTURE OF SUCH SALTS
ES2211996T3 (en) UNION AGENTS FOR HIALURONIC ACID RECEPTORS AND THEIR USE FOR TUMOR TREATMENT OR RESISTANCE.